XML 42 R30.htm IDEA: XBRL DOCUMENT v3.25.3
REVENUE (Tables)
9 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue by Segment by Geographic Area
Revenue by segment and geography based on shipped to locations for the three and nine months ended September 30, 2025 and 2024 were as follows:
For the Three Months Ended September 30, 2025
SegmentEuropeDomesticLatin
America
AsiaTotal
Aptar Pharma$208,055 $157,606 $10,968 $68,781 $445,410 
Aptar Beauty196,137 57,012 42,132 32,487 327,768 
Aptar Closures61,611 85,110 22,031 19,201 187,953 
Total$465,803 $299,728 $75,131 $120,469 $961,131 
For the Three Months Ended September 30, 2024
SegmentEuropeDomesticLatin
America
AsiaTotal
Aptar Pharma$204,835 $142,747 $10,925 $62,087 $420,594 
Aptar Beauty182,708 59,954 37,565 22,632 302,859 
Aptar Closures57,586 88,870 20,665 18,717 185,838 
Total$445,129 $291,571 $69,155 $103,436 $909,291 
For the Nine Months Ended September 30, 2025
SegmentEuropeDomesticLatin
America
AsiaTotal
Aptar Pharma$618,577 $460,429 $36,469 $181,991 $1,297,466 
Aptar Beauty589,282 172,041 124,625 82,376 968,324 
Aptar Closures172,585 259,464 62,693 53,913 548,655 
Total$1,380,444 $891,934 $223,787 $318,280 $2,814,445 
For the Nine Months Ended September 30, 2024
SegmentEuropeDomesticLatin
America
AsiaTotal
Aptar Pharma$624,503 $407,291 $36,848 $173,778 $1,242,420 
Aptar Beauty579,638 189,849 117,959 64,220 951,666 
Aptar Closures165,507 262,154 64,221 48,834 540,716 
Total$1,369,648 $859,294 $219,028 $286,832 $2,734,802 
Schedule of Contract Assets and Contract Liabilities
The opening and closing balances of our contract asset and contract liabilities were as follows:
Balance as of September 30, 2025Balance as of December 31, 2024Increase/
(Decrease)
Contract asset (current)$13,132 $12,571 $561 
Contract liability (current)82,931 64,425 18,506 
Contract liability (long-term)50,381 40,551 9,830